Bacterial Growth on a Microfluidic Chip to Study Antibiotic Drug Resistance
JoVE Encyclopedia of Experiments
Microbiology
0 views • 2:45 min • September 26th, 2025
Loading...
Overview
This article demonstrates the use of a microfluidic chip system to visualize and compare the growth and morphology of wild-type and trimethoprim-resistant (tmp-resistant) E. coli strains under trimethoprim (TMP) antibiotic stress. The protocol details the preparation, loading, and imaging of bacterial samples to assess antibiotic resistance phenotypes in real time.
Key Study Components
Area of Science
- Microbiology
- Antibiotic resistance
- Microfluidics
Background
- Antibiotic resistance in bacteria is a major public health concern.
- Trimethoprim (TMP) targets dihydrofolate reductase (DHFR) in E. coli, inhibiting bacterial growth.
- Mutations in DHFR can confer resistance to TMP.
- Microfluidic devices enable controlled, real-time observation of bacterial responses to antibiotics.
Purpose of Study
- To compare the morphological and growth responses of wild-type and TMP-resistant E. coli under TMP stress.
- To demonstrate the utility of a microfluidic chip for studying adaptive evolution and antibiotic resistance.
- To provide a reproducible protocol for visualizing bacterial adaptation to antibiotics.
Methods Used
- Preparation of microfluidic chips with separate growth and drug chambers, divided by a micromechanical valve.
- Loading of wild-type and TMP-resistant E. coli strains into growth chambers using pressure.
- Introduction of TMP-containing media into drug chambers and controlled diffusion into growth chambers.
- Time-lapse imaging using an inverted microscope and CCD camera to monitor bacterial morphology and multiplication over eight hours.
- Daily sample thawing, inoculation, and dilution steps to maintain bacterial cultures.
- Quantification of cell numbers according to a defined protocol.
Main Results
- Wild-type E. coli exposed to TMP exhibited filamentation and reduced multiplication, indicating antibiotic-induced stress.
- TMP-resistant mutant E. coli maintained normal morphology and multiplication under TMP exposure, demonstrating resistance.
- The microfluidic chip enabled clear visualization and comparison of antibiotic effects on different bacterial strains.
- Quantitative cell number data supported morphological observations.
Conclusions
- The microfluidic chip system is effective for real-time visualization of bacterial adaptation to antibiotics.
- Wild-type and resistant strains display distinct morphological and growth responses under TMP stress.
- This approach facilitates detailed studies of antibiotic resistance mechanisms and adaptive evolution in bacteria.
Frequently Asked Questions
What is the main advantage of using a microfluidic chip in this study?
The microfluidic chip allows precise control of antibiotic exposure and real-time imaging of bacterial growth and morphology, enabling detailed comparison between wild-type and resistant strains.
How does trimethoprim (TMP) affect wild-type E. coli?
TMP binds to dihydrofolate reductase in wild-type E. coli, inhibiting its function, which leads to filamentation and reduced bacterial multiplication.
Why does the TMP-resistant mutant strain not show filamentation under TMP stress?
The mutant strain has an altered DHFR structure that prevents TMP binding, allowing normal cell division and morphology even in the presence of the antibiotic.
How are bacterial samples prepared for loading into the microfluidic chip?
Samples are thawed, inoculated into fresh M9 medium, incubated overnight, diluted tenfold, and then loaded into the chip using pressure.
What imaging technique is used to monitor bacterial growth in this protocol?
Time-lapse imaging is performed using an inverted microscope equipped with a CCD camera, capturing images every hour for eight hours.
How is the interaction between bacteria and antibiotic initiated in the chip?
A micromechanical valve is actuated to allow TMP to diffuse from the drug chamber into the growth chamber, exposing bacteria to the antibiotic.
What data is collected to assess bacterial response to TMP?
Both morphological changes (such as filamentation) and quantitative cell number data are collected to evaluate the effects of TMP on wild-type and resistant strains.
Executive Industry Relevance
Microfluidic chip-based bacterial growth assays enable real-time, quantitative assessment of antibiotic resistance phenotypes, supporting early-stage target validation and mechanistic de-risking in anti-infective discovery. This approach provides predictive confidence for distinguishing resistant from susceptible strains, informing portfolio triage and prioritization of antibacterial candidates. Integration of quantitative imaging and controlled drug exposure enhances translational continuity from discovery to preclinical evaluation.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables direct interrogation of antibiotic mechanism-of-action and resistance pathways in live bacterial systems.
- Supports functional validation of resistance-conferring mutations through comparative growth and morphology analysis.
- Provides predictive confidence for target engagement and biological de-risking in anti-infective programs.
Screening & Assay Development
- Facilitates preparation of validated bacterial models for downstream compound screening workflows.
- Delivers standardized, reproducible, and quantitative outputs for growth inhibition and morphological changes.
- Enables high-content imaging and data collection suitable for screening scalability and platform reuse.
Translational & Preclinical Research
- Aligns in vitro resistance phenotyping with translational biomarker strategies for preclinical validation.
- Supports continuity from early discovery through preclinical assessment of candidate antibiotics.
- Provides mechanistic insights that inform risk-adjusted advancement decisions in anti-infective portfolios.
Pipeline & Workflow Integration
This microfluidic assay positions within the discovery-to-preclinical continuum, bridging early mechanistic studies and translational resistance profiling.
- Discovery Biology: Enables hypothesis testing of resistance mechanisms and clarifies antibiotic action at the cellular level.
- Screening: Provides reproducible, quantitative readouts for compound evaluation and assay standardization.
- Analytics: Generates cell count and morphological data to compare wild-type and resistant strains under drug pressure.
- Translational Research: Supports alignment of in vitro resistance data with preclinical biomarker strategies.
- Enterprise Reuse: Offers a reusable platform for diverse antibiotic and bacterial strain testing across programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in resistance mechanism validation and reduces mechanistic ambiguity.
- Operational Value: Delivers standardized, scalable, and reproducible workflows for anti-infective R&D.
- Strategic Value: Improves go/no-go decision-making and capital efficiency by enabling early biological risk assessment.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of antibacterial candidates.
Implementation Considerations
- Requires expertise in microfluidics, bacterial culture, and quantitative imaging analysis.
- Needs access to microfluidic fabrication, pressure-loading systems, and time-lapse microscopy infrastructure.
- Demands cross-team standardization of sample preparation and imaging protocols for reproducibility.
- Adaptation may be needed for different bacterial species or antibiotic classes.
- Practical limitations include throughput constraints and the need for precise environmental control.
Biopharma FAQs
Why does null hypothesis testing matter for microfluidic antibiotic resistance assays?
Null hypothesis testing enables objective comparison of growth and morphology between wild-type and resistant strains, supporting rigorous target validation and reducing false-positive resistance claims in early discovery.
How does independent variable isolation fit the microfluidic chip workflow?
The microfluidic chip design allows precise isolation of antibiotic exposure as the independent variable, ensuring that observed phenotypic differences are attributable to drug action rather than confounding factors.
What do quantitative cell number measurements enable in resistance studies?
Quantitative cell counts provide reproducible metrics for assessing bacterial growth inhibition and resistance, enabling data-driven comparison of strain responses and supporting robust assay development.
Why are replication requirements critical for cross-functional collaboration?
Replication of microfluidic assays ensures data reliability and reproducibility, facilitating cross-team validation and integration of results into broader anti-infective R&D workflows.
What statistical analysis capabilities are required before implementing microfluidic resistance assays?
Statistical analysis of cell count and morphological data is essential for distinguishing true resistance phenotypes, informing go/no-go decisions, and supporting portfolio-level advancement of antibacterial candidates.
10:49
Antibiotic Dereplication Using the Antibiotic Resistance Platform
Related Videos
0 Views
08:23
Visualization of Bacterial Resistance using Fluorescent Antibiotic Probes
Related Videos
0 Views
08:58
Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Related Videos
0 Views
14:25
Window on a Microworld: Simple Microfluidic Systems for Studying Microbial Transport in Porous Media
Related Videos
0 Views
03:27
Microfluidic Patterning and Fluorescence-Based Tracking of Single-Cell Bacterial Growth
Related Videos
0 Views
05:02
Microfluidic Time-Lapse Microscopy to Study Antibiotic Persistence in Bacteria
Related Videos
0 Views
03:20
Real-Time Monitoring of Bacterial Growth Using a Microfluidic Microdroplet Culture System
Related Videos
0 Views
02:53
Tracking Bacterial Growth at Single-Cell Resolution in a Microfluidic System
Related Videos
0 Views
12:04
Microfluidic Picoliter Bioreactor for Microbial Single-cell Analysis: Fabrication, System Setup, and Operation
Related Videos
0 Views
12:41
Stress-induced Antibiotic Susceptibility Testing on a Chip
Related Videos
0 Views
Last updated: 15 August 2026